Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Navicare Biotech Co., Ltd. (8472) Income Statement

Navicare Biotech Co., Ltd. Income Statement

Last quarter (Q2 2026), Navicare Biotech Co., Ltd.'s total revenue was NT$125.91M, a decrease of 7.03% from the same quarter last year. In Q2, Navicare Biotech Co., Ltd.'s net income was NT$-7.01M. See Navicare Biotech Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Mar 23Dec 21
NT$ 478.07MNT$ 337.03MNT$ 388.50MNT$ 331.55MNT$ 305.28M
NT$ 172.16MNT$ 211.87MNT$ 281.82MNT$ 280.10MNT$ 283.92M
NT$ 203.98MNT$ 288.65MNT$ 371.98MNT$ 345.57MNT$ 297.70M
Depreciation and AmortizationNT$ 16.73MNT$ 18.67MNT$ 16.70MNT$ 12.92MNT$ 10.35M
NT$ -15.09MNT$ -54.05MNT$ -46.75MNT$ -81.95MNT$ 22.46M
NT$ -31.82MNT$ -76.78MNT$ -90.16MNT$ -53.45MNT$ 12.12M
NT$ 11.05MNT$ -1.54MNT$ 21.72MNT$ -30.18MNT$ 28.89M
NT$ -20.77MNT$ -78.32MNT$ -68.44MNT$ -95.98MNT$ 15.10M
NT$ -23.27MNT$ -78.46MNT$ -51.83MNT$ -82.68MNT$ 10.77M
Per Share Metrics
Basic EPSNT$ -1.31NT$ -4.41NT$ -2.92NT$ -4.66NT$ 0.61
Diluted EPSNT$ -1.31NT$ -4.41NT$ -2.92NT$ -4.66NT$ 0.61
Weighted Average Shares Outstanding17.77M17.74M17.74M17.74M17.74M
Weighted Average Shares Outstanding (Diluted)17.77M17.74M17.74M17.74M17.76M

Currency in TWD

Navicare Biotech Co., Ltd. Earnings and Revenue History

-300M0300M600M-30 %-15 %0 %15 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin